Assessment of [18F]MNI-1054 as a Marker for LSD1
NCT03695926
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
4
Enrollment
OTHER
Sponsor class
Conditions
Healthy Volunteers (HV)
Interventions
DRUG:
[18F]MNI-1054
Sponsor
Invicro